Status: Recruiting
Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
The purpose of this study is to test the safety of combining the disulfiram (DSF) and copper gluconate (Cu) to liposomal doxorubicin to treat patients with sarcomas that recurred or did not respond to initial treatment.
Participants needed: 24
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Case Comprehensive Cancer CenterUpdated: Jun 5, 2026Locations: 1
Eligibility criteria
Must have histologically confirmed relapsed or refractory sarcoma. [+14]
Has active, uncontrolled bacterial, viral, or fungal infection(s) requiring syst... [+6]